Show simple item record

dc.contributor.authorRieck, Åshild Elsethen_US
dc.contributor.authorGerdts, Evaen_US
dc.contributor.authorLønnebakken, Mai Toneen_US
dc.contributor.authorBahlmann, Eddaen_US
dc.contributor.authorCioffi, Giovannien_US
dc.contributor.authorGohlke-Bärwolf, Christaen_US
dc.contributor.authorRay, Simonen_US
dc.contributor.authorCramariuc, Danaen_US
dc.description.abstractIntroduction: Valvuloarterial impedance (Zva) is a measure of global (combined valvular and arterial) load opposing left ventricular (LV) ejection in aortic stenosis (AS). The present study identified covariates and tested the prognostic significance of global LV load in patients with asymptomatic AS. Methods: 1418 patients with mild-moderate, asymptomatic AS in the Simvastatin Ezetimibe in Aortic Stenosis (SEAS) study were followed for a mean of 43±14 months during randomized, placebo-controlled treatment with combined simvastatin 40 mg and ezetimibe 10 mg daily. High global LV load was defined as Zva >5 mm Hg/ml/ m2. The impact of baseline global LV load on rate of major cardiovascular (CV) events, aortic valve events and total mortality was assessed in Cox regression models reporting hazard ratio (HR) and 95% Confidence Intervals (CI). Results: High global LV load was found in 18% (n=252) of patients and associated with female gender, higher age, hypertension, more severe AS and lower ejection fraction (all p<0.05). A total of 476 major CV events, 444 aortic valve events and 132 deaths occurred during follow-up. In multivariate Cox regression analyses, high global LV load predicted higher rate of major CV events (HR 1.35 [95% CI 1.08-1.71], P=0.010) and aortic valve events (HR 1.41 [95% CI 1.12-1.79], P=0.004) independent of hypertension, LV ejection fraction, female gender, age, abnormal LV geometry and AS severity, but failed to predict mortality. Conclusion: In asymptomatic AS, assessment of global LV load adds complementary information on prognosis to that provided by hypertension or established prognosticators like AS severity and LV ejection fraction.en_US
dc.publisherBioMed Centraleng
dc.rightsAttribution CC BYeng
dc.subjectAortic valve stenosiseng
dc.subjectValvuloarterial impedanceeng
dc.titleGlobal left ventricular load in asymptomatic aortic stenosis: covariates and prognostic implication (the SEAS trial)en_US
dc.typePeer reviewed
dc.typeJournal article
dc.rights.holderCopyright 2012 Rieck et al.; licensee BioMed Central Ltd.
dc.rights.holderÅshild E Rieck et al.; licensee BioMed Central Ltd.
dc.source.journalCardiovascular Ultrasound

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution CC BY
Except where otherwise noted, this item's license is described as Attribution CC BY